Report Detail

Chemical & Material COVID-19 Impact on Global Dihydroartemisinin, Market Insights and Forecast to 2026

  • RnM4075886
  • |
  • 24 June, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

Dihydroartemisinin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dihydroartemisinin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Dihydroartemisinin market is segmented into
Pharmaceutical Grade
Industrial Grade

Segment by Application, the Dihydroartemisinin market is segmented into
Malaria Treatment
Scientific Research
Others

Regional and Country-level Analysis
The Dihydroartemisinin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dihydroartemisinin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dihydroartemisinin business, the date to enter into the Dihydroartemisinin market, Dihydroartemisinin product introduction, recent developments, etc.
The major vendors covered:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd


1 Study Coverage

  • 1.1 Dihydroartemisinin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Dihydroartemisinin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Dihydroartemisinin Market Size Growth Rate by Type
    • 1.4.2 Pharmaceutical Grade
    • 1.4.3 Industrial Grade
  • 1.5 Market by Application
    • 1.5.1 Global Dihydroartemisinin Market Size Growth Rate by Application
    • 1.5.2 Malaria Treatment
    • 1.5.3 Scientific Research
    • 1.5.4 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Dihydroartemisinin Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Dihydroartemisinin Industry
      • 1.6.1.1 Dihydroartemisinin Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Dihydroartemisinin Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Dihydroartemisinin Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Dihydroartemisinin Market Size Estimates and Forecasts
    • 2.1.1 Global Dihydroartemisinin Revenue 2015-2026
    • 2.1.2 Global Dihydroartemisinin Sales 2015-2026
  • 2.2 Dihydroartemisinin Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Dihydroartemisinin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Dihydroartemisinin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Dihydroartemisinin Competitor Landscape by Players

  • 3.1 Dihydroartemisinin Sales by Manufacturers
    • 3.1.1 Dihydroartemisinin Sales by Manufacturers (2015-2020)
    • 3.1.2 Dihydroartemisinin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Dihydroartemisinin Revenue by Manufacturers
    • 3.2.1 Dihydroartemisinin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Dihydroartemisinin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Dihydroartemisinin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2019
    • 3.2.5 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Dihydroartemisinin Price by Manufacturers
  • 3.4 Dihydroartemisinin Manufacturing Base Distribution, Product Types
    • 3.4.1 Dihydroartemisinin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Dihydroartemisinin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Dihydroartemisinin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Dihydroartemisinin Market Size by Type (2015-2020)
    • 4.1.1 Global Dihydroartemisinin Sales by Type (2015-2020)
    • 4.1.2 Global Dihydroartemisinin Revenue by Type (2015-2020)
    • 4.1.3 Dihydroartemisinin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Dihydroartemisinin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Dihydroartemisinin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Dihydroartemisinin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Dihydroartemisinin Market Size by Application (2015-2020)
    • 5.1.1 Global Dihydroartemisinin Sales by Application (2015-2020)
    • 5.1.2 Global Dihydroartemisinin Revenue by Application (2015-2020)
    • 5.1.3 Dihydroartemisinin Price by Application (2015-2020)
  • 5.2 Dihydroartemisinin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Dihydroartemisinin by Country
    • 6.1.1 North America Dihydroartemisinin Sales by Country
    • 6.1.2 North America Dihydroartemisinin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Dihydroartemisinin Market Facts & Figures by Type
  • 6.3 North America Dihydroartemisinin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Dihydroartemisinin by Country
    • 7.1.1 Europe Dihydroartemisinin Sales by Country
    • 7.1.2 Europe Dihydroartemisinin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Dihydroartemisinin Market Facts & Figures by Type
  • 7.3 Europe Dihydroartemisinin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Dihydroartemisinin by Region
    • 8.1.1 Asia Pacific Dihydroartemisinin Sales by Region
    • 8.1.2 Asia Pacific Dihydroartemisinin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Dihydroartemisinin Market Facts & Figures by Type
  • 8.3 Asia Pacific Dihydroartemisinin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Dihydroartemisinin by Country
    • 9.1.1 Latin America Dihydroartemisinin Sales by Country
    • 9.1.2 Latin America Dihydroartemisinin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Dihydroartemisinin Market Facts & Figures by Type
  • 9.3 Central & South America Dihydroartemisinin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Dihydroartemisinin by Country
    • 10.1.1 Middle East and Africa Dihydroartemisinin Sales by Country
    • 10.1.2 Middle East and Africa Dihydroartemisinin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Dihydroartemisinin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Dihydroartemisinin Products Offered
    • 11.1.5 Sanofi Recent Development
  • 11.2 KPC Pharmaceuticals
    • 11.2.1 KPC Pharmaceuticals Corporation Information
    • 11.2.2 KPC Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.2.3 KPC Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
    • 11.2.5 KPC Pharmaceuticals Recent Development
  • 11.3 Guangxi Xiancaotang Pharmaceutical
    • 11.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
    • 11.3.2 Guangxi Xiancaotang Pharmaceutical Description, Business Overview and Total Revenue
    • 11.3.3 Guangxi Xiancaotang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
    • 11.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
  • 11.4 Guilin Pharmaceutical
    • 11.4.1 Guilin Pharmaceutical Corporation Information
    • 11.4.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
    • 11.4.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
    • 11.4.5 Guilin Pharmaceutical Recent Development
  • 11.5 Kerui Nanhai Pharmaceutical
    • 11.5.1 Kerui Nanhai Pharmaceutical Corporation Information
    • 11.5.2 Kerui Nanhai Pharmaceutical Description, Business Overview and Total Revenue
    • 11.5.3 Kerui Nanhai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
    • 11.5.5 Kerui Nanhai Pharmaceutical Recent Development
  • 11.6 Shanghai Natural Bio-engineering Co
    • 11.6.1 Shanghai Natural Bio-engineering Co Corporation Information
    • 11.6.2 Shanghai Natural Bio-engineering Co Description, Business Overview and Total Revenue
    • 11.6.3 Shanghai Natural Bio-engineering Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
    • 11.6.5 Shanghai Natural Bio-engineering Co Recent Development
  • 11.7 Novanat Bioresource
    • 11.7.1 Novanat Bioresource Corporation Information
    • 11.7.2 Novanat Bioresource Description, Business Overview and Total Revenue
    • 11.7.3 Novanat Bioresource Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
    • 11.7.5 Novanat Bioresource Recent Development
  • 11.8 Botanical Extracts EPZ Ltd
    • 11.8.1 Botanical Extracts EPZ Ltd Corporation Information
    • 11.8.2 Botanical Extracts EPZ Ltd Description, Business Overview and Total Revenue
    • 11.8.3 Botanical Extracts EPZ Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
    • 11.8.5 Botanical Extracts EPZ Ltd Recent Development
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description, Business Overview and Total Revenue
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Dihydroartemisinin Products Offered
    • 11.1.5 Sanofi Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Dihydroartemisinin Market Estimates and Projections by Region
    • 12.1.1 Global Dihydroartemisinin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Dihydroartemisinin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Dihydroartemisinin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Dihydroartemisinin Sales Forecast (2021-2026)
    • 12.2.2 North America: Dihydroartemisinin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Dihydroartemisinin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Dihydroartemisinin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Dihydroartemisinin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Dihydroartemisinin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Dihydroartemisinin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Dihydroartemisinin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Dihydroartemisinin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Dihydroartemisinin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Dihydroartemisinin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Dihydroartemisinin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Dihydroartemisinin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Dihydroartemisinin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Dihydroartemisinin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Dihydroartemisinin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Dihydroartemisinin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Dihydroartemisinin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Dihydroartemisinin. Industry analysis & Market Report on COVID-19 Impact on Global Dihydroartemisinin is a syndicated market report, published as COVID-19 Impact on Global Dihydroartemisinin, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Dihydroartemisinin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report